We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company
Gold Supplier
Blood Glucose Reference Analyzer
Nova Primary
New
Mycoplasma Pneumoniae Assay
SeroMP
New
POC Single-Use IVD Test
i-STAT CHEM8+ Cartridge
New
Liquid Urinalysis Control
URiTROL
Visit expo >

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Image: Artificial intelligence predicts genetics of cancerous brain tumors in under 90 seconds (Photo courtesy of Michigan Medicine)

AI-Based Diagnostic Screening System Predicts Genetics of Cancerous Brain Tumors in 90 Seconds

Researchers have developed an artificial intelligence (AI) system that can screen for genetic mutations in cancerous brain tumors in less than 90 seconds, potentially streamlining the diagnosis and treatment of gliomas. More...
24 Mar 2023
Image: Syn-One Test is the only commercially available skin-based test that aids diagnosis of synucleinopathies (Photo courtesy of CND)

Non-Invasive Skin Biopsy Test Allows Clinicians to Look inside Nerves for Diagnosing Neurodegenerative Disorders

CND Life Sciences has developed the first-ever test in the market that can examine the nerves inside the human body and detect protein accumulation in individuals with synucleinopathies such as Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, pure autonomic failure, and REM sleep behavior disorder. More...
24 Mar 2023
Image: The novel technology uses fringe-field capacitive sensing to quantify molecular targets (Photo courtesy of AltraTech)

Next Gen Technology Enables Robust, Straightforward and Flexible Molecular Diagnostics in Any Environment

A next-generation ‘Anywhere, anytime, by anyone’ molecular detection technology aims to shift the detection and monitoring of viral infections to point-of-care and beyond clinical settings. The technology, which allows for rapid and precise measurement and quantification of viral RNA, DNA, antigens, or antibodies, can be used by anyone, anywhere, at any time. More...
24 Mar 2023
Image: The Genomadix Cube can go places where access to diagnostic testing may have previously been limited (Photo courtesy of Genomadix)

Portable PCR Molecular Analyzer Delivers Time-Critical Results in Near-Patient Setting

Conventional laboratory-based tests may require several days or weeks to generate results. Now, a fast, accurate, and portable DNA analyzer goes from sample to result in approximately an hour, making results more accessible. More...
24 Mar 2023
Image: The new assay enables accurate prognosis and detection data for those prone to esophageal cancer (Photo courtesy of Previse)

First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer

Barrett's esophagus is the sole precursor known and is a significant risk factor for the development of esophageal cancer. It is crucial to identify patients with Barrett's esophagus who will go on to develop high-grade dysplasia or esophageal cancer in the future. Now, a new test can meet this important unmet medical need by enabling accurate prognosis and detection data for individuals who may be susceptible to esophageal cancer. More...
23 Mar 2023
Image: Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel (Photo courtesy of Roche)

Roche and Eli Lilly Collaborate on Innovative Blood Test for Early Diagnosis of Alzheimer's

Roche has entered into a collaboration with Eli Lilly to support the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP) - an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease. More...
23 Mar 2023
Image: Wearable microscopes advance spinal cord imaging in mice (Photo courtesy of Salk Institute)

Wearable Microscopes Offer Insight into Inaccessible Spinal Cord Regions

Scientists have developed wearable microscopes that offer unprecedented insight into the signaling patterns that occur within the spinal cords of mice. This technological breakthrough will significantly improve researchers' understanding of the neural basis of movement and sensations in both healthy and disease contexts, like chronic pain, itch, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). More...
22 Mar 2023
Copyright © 2000-2023 Globetech Media. All rights reserved.